Machine learning program provides more accurate understanding of peptide sequences in cells

Machine learning is now helping researchers analyze the makeup of unfamiliar cells, which could lead to more personalized medicine in the treatment of cancer and other serious diseases.

Chatbot Care Managers? ACOs Should be Cautious in AI Adoption

Theresa Hush, CEO and Co-founder of Roji Health Intelligence Given Artificial Intelligence’s potential to improve patient care and reduce costs, it’s no surprise that AI

September 27, 2023

Amgen gives first glimpse at PRMT5 inhibitor, days after Bristol Myers put a $1B promise on the target

In a first look at Amgen’s experimental PRMT5 inhibitor, roughly 16% of patients with various cancers saw their tumors shrink by at least 30%, equating

October 14, 2023

Metrion Biosciences expands senior leadership team with appointments of Dr Robert Kirby as COO and Dr Edward Stevens as CSO

Metrion Biosciences Limited (“Metrion”), is a specialist ion channel contract research and drug discovery company.

July 6, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.